European Archives - Page 795 of 1217 - European Medical Journal

Switching off Inflammation with Diet: A Review of Exclusive Enteral Nutrition in Children with Crohn’s Disease

The inflammatory bowel diseases (IBD) are a group of conditions characterised by chronic, incurable inflammation in the gastrointestinal (GI) tract…

A Rare Case of an Inflammatory Myofibroblastic Tumour of the Colon as a Probable Result of Tumour Recurrence after Hemicolectomy

Inflammatory myofibroblastic tumour (IMT) is a rare mesenchymal solid tumour commonly documented in children and young adults, but also found…

Possibility of Link Between Dopamine and Childhood Asthma

The NEUROTRANSMITTER dopamine has been shown, in the latest research, to play a key role in development of the sympathetic nerves of the mouse lung in…

Nanoparticle-Immunotherapy as a Novel Treatment for Lung Cancer

INHALABLE nanoparticles have been shown success in animal models to treat lung cancer. The study, carried out by a team supervised by Professor Dawen Zhao…

Building a R&D strategy for the modern age

Low levels of return on investment in R&D is an issue that has been bubbling beneath the surface of pharmaceutical companies for some time and the situation is coming to a head, threatening the industry’s future

Creating the patient-centred trial

Patient recruitment and retention remain the biggest challenges in clinical studies, it is surely time for industry to trial a new approach.

The history of medical affairs

Learn about the origins of the medical affairs function, how far it’s come and where it may be heading in the future as key proprietor of patient centricity.

Ipsen’s Isabelle Bocher-Pianka on patient-centric pharma evolution

Isabelle Bocher-Pianka, Chief Patient Affairs Officer, Global Medical Affairs, Ipsen shares her thoughts on pharma’s mission to help improve patient lives, challenges that hinder patient centricity and seeking knowledge across industries.

Pharma: the social butterfly

The internet is a jungle, tangled and overgrown, dense with information overload. Among the unkempt chaos lies social media: a treasure trove of possibilities for the pharmaceutical industry.

ESC 2019 – Interview – Dr Çetin Erol

An interview with Dr Çetin Erol, İbn-i Sina Hospital, Faculty of Medicine, Department of Cardiology, Ankara University, Ankara, Turkey, at this year’s ESC…